Vitamin D insufficiency tied to increased incidence of cutaneous melanoma
USA: Findings from a meta-analysis suggest the importance of identifying vitamin D insufficiency for evaluating and treating patients at a higher risk of developing cutaneous melanoma (CM).
The researchers, in their study published in Melanoma Research, identified an association between increased incidence of cutaneous melanoma and vitamin D insufficiency. They also observed less favourable Breslow tumour depth with lower vitamin D levels and the presence of vitamin D insufficiency.
The study showed that a vitamin D level <20 ng/dL was linked with an increased incidence of cutaneous melanoma (RR, 1.45). A vitamin D level >20 ng/dL was correlated with Breslow depth <1 mm and a lower vitamin D level was associated with Breslow depth >1 mm.
Cutaneous melanoma is the deadliest skin cancer, and vitamin D insufficiency has been indicated as a risk factor. Richard A Shellenberger, Trinity Health Ann Arbor Hospital, Ann Arbor, Michigan, and colleagues sought to explore the relationship between both vitamin D insufficiency and 25-hydroxy vitamin D levels with the incidence and stage of CM in a systematic review and meta-analysis.
For this purpose, the researchers searched five databases from inception until 11 July 2022. Case-control and cohort studies that reported mean 25-hydroxy vitamin D levels or the presence of vitamin D insufficiency in CM patients and compared with healthy controls; or those that reported vitamin D insufficiency and Breslow tumour depth or the development of metastasis in CM were included. A total of fourteen studies were included in the analysis.
The authors reported the following findings:
- Statistically significant relationships were found between vitamin D level <20 ng/dl and incidence of CM [pooled RR 1.45; lower mean vitamin D level and Breslow depth >1 mm (SMD 0.19); and vitamin D level >20 ng/dl and Breslow depth <1 mm (pooled RR 0.69).
- Statistical significance was not found in the relationships between vitamin D levels and the presence of metastasis (pooled SMD −0.13); or mean vitamin D level and the incidence of CM (pooled SMD −0.39).
"Identification of vitamin D insufficiency may be critical for evaluating and treating patients at a higher risk of developing CM," the researchers concluded.
Reference:
Shellenberger, Richard A.a; Gowda, Sunainaa; Kurn, Heidia; Albright, Jeremyb; Mayo, MacKenzie H.a. Vitamin D insufficiency and serum levels related to the incidence and stage of cutaneous melanoma: a systematic review and meta-analysis. Melanoma Research 33(4):p 265-274, August 2023. | DOI: 10.1097/CMR.0000000000000897
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.